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Abstract 1 
Low heart rate variability (HRV) predicts sudden cardiac death. Long chain (LC) n-3 PUFA 2 
(C20-C22) status is positively associated with HRV. This cross-sectional study investigated 3 
whether vegans aged 40-70 y (n 23), whose diets are naturally free from eicosapentaenoic 4 
acid (EPA; 20 : 5n-3) and docosahexaenoic acid (DHA; 22 : 6n-3), have lower HRV 5 
compared to omnivores (n 24). Proportions of LC n-3 PUFA in erythrocyte membranes, 6 
plasma fatty acids, and concentrations of plasma LC n-3 PUFA-derived lipid mediators were 7 
significantly lower in vegans. Day-time interbeat intervals (IBI), adjusted for physical 8 
activity, age, BMI and sex, were significantly shorter in vegans compared to omnivores: 9 
mean difference -67 ms (95% CI -130, -3.4), P <0.05, but there were no significant 10 
differences over 24 h or during sleep. Vegans had higher overall HRV, measured as 24 h 11 
SDNN (mean adjusted difference 27 msec, 95% CI 1, 52, P = 0.039). Conversely, vegans 12 
presented with decreased 8 h day-time HRV: mean adjusted difference in SDNN -20 msec 13 
(95% CI -37, -3), P = 0.021, with no differences during nocturnal sleep. Day-time parameters 14 
of beat-to-beat HRV (RMSSD, PNN50% and HF) were similarly lower in vegans, with no 15 
differences during sleep. In conclusion, vegans have higher 24 h SDNN, but lower day-time 16 
HRV and shorter day-time IBI relative to comparable omnivores. Vegans may have reduced 17 
availability of precursor markers for proresolving lipid mediators; it remains to be determined 18 
whether there is a direct link with impaired cardiac function in populations with low omega-3 19 
status. 20 
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INTRODUCTION 21 
The longer chain (LC) n-3 PUFA (C20-C22), eicosapentaenoic acid (EPA; 20 : 5n-3) and 22 
docosahexaenoic acid (DHA; 22 : 6n-3), are mainly derived from seafood, although small 23 
amounts are provided by meat, eggs and dairy products. Consequently, vegans consume a 24 
diet devoid of 20 : 5n-3 and 22 : 6n-3 (1). The main n-3 PUFA in vegan diets is α-linolenic 25 
acid (ALA; 18 : 3n-3), derived from plant foods, particularly soya and seed oils such as 26 
rapeseed oil. (LC) n-3 PUFA as percentages of total fatty acids in blood fractions are, in 27 
vegans, only a third of the level in meat- and fish-eaters (2). 20 : 5n-3 and 22 : 6n-3 can be 28 
endogenously synthesised from 18 : 3n-3 by desaturation and elongation enzymes, but the 29 
rate of this conversion is restricted to a narrow range in adults (3). Stable isotope studies have 30 
suggested that conversion of 18 : 3n-3  to 22 : 6n-3 can vary from undetectable amounts up to 31 
4% in men, and 9% in women (4). An observational study suggested that conversion from 32 
dietary 18 : 3n-3 to longer chain n-3 PUFA might be increased in non-fish eaters(5). 33 
Furthermore, dietary supplementation of vegans with 18 : 3n-3 has not been found to increase 34 
22 : 6n-3 in blood lipids, including plasma choline phosphoglycerides and platelet 35 
phosphoglycerides (6; 7) and erythrocytes, platelets, and plasma cholesteryl esters, 36 
phospholipids and triglycerides (6; 7). It is unclear whether the lack of 20 : 5n-3 and 22 : 6n-3 37 
intake in vegans has adverse effects on cardiovascular health(8; 9) especially as body mass 38 
index(10; 11), blood cholesterol(12; 13) and blood pressure(14; 15) are lower than in meat-eaters.  39 
LC n-3 PUFA, especially 22 : 6n-3, are rapidly incorporated into cellular lipids,  primarily 40 
membrane phospholipids, in a variety of cells including cardiomyocytes and neural tissue, 41 
thereby influencing membrane properties and function of membrane proteins. Fish oil 42 
consumption reduces HR in humans(16). Increasing LC n-3 PUFA content in cardiomyocyte 43 
membranes by 3-wk of dietary fish oil in rabbits decreases HR in isolated hearts, and reduces 44 
pacemaker activity and pacemaker current in sinoatrial node cells(17); mechanisms are likely 45 
to be related to increased membrane fluidity and direct interaction with a hyperpolarisation-46 
activated If channel protein(17), altering ion channel currents and reducing intrinsic pacemaker 47 
rate, reviewed by Billman(18).  48 
Raised heart rates are associated with a high degree of sympathetic activity and suppressed 49 
parasympathetic activity (vagal activity slows heart rate ) resulting in low HRV; a reduced 50 
capacity to self-regulate the heart rate in response to physiological demands. Low HRV is 51 
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associated with mortality after a myocardial infarction (19; 20; 21), risk of sudden death in 52 
patients with coronary heart disease (22), and risk of cardiac events in the general population 53 
(23). Higher n-3 PUFA tissue status or fish consumption has been positively associated with 54 
HRV (24; 25). Since HRV is under the control of the autonomic nervous system, regulation of 55 
HR may be influenced by n-3 PUFA status of neuronal and cardiac tissue. The brain is 56 
particularly rich in 22 : 6n-3, and incorporation of dietary LC n-3 PUFA into neuronal tissue 57 
influences gene expression, membrane protein signalling, neurotransmission and signal 58 
transduction pathways(26). This may influence autonomic function by enhancing 59 
parasympathetic and/or reducing sympathetic activity, thus reducing HR and increasing 60 
HRV. Therefore, impairment of cardiac autonomic function due to depleted LC n-3 PUFA 61 
content in the central or peripheral nervous tissue would reduce the responsivity of the heart.  62 
A further mechanism whereby cardiac function may be modulated by neuronal LC n-3 PUFA 63 
status is via the production of eicosanoids and related PUFA-derived lipid mediators that may 64 
reduce inflammation and terminate (“resolve”) acute inflammatory events, preventing further 65 
neuronal tissue damage. PUFAs can be oxygenated into numerous bioactive lipid mediators 66 
(27), and some of the 20 : 5n-3 and 22 : 6n-3 derived species act as precursors of the 67 
specialised pro-resolving lipid mediators (SPMs), resolvins, protectins and maresin, which 68 
are autocoid substances actively involved in the resolution of local inflammation(27; 28; 29). 69 
Neuroprotectin D-1 (NPD1) is a neuroprotective lipid mediator derived from 22 : 6n-3 which 70 
might be particularly relevant to the preservation of optimal cardiac autonomic function(30). 71 
This study aims to compare HRV between vegans and age/sex/BMI-matched omnivores, 72 
representing populations with low and adequate tissue n-3 PUFA status, respectively. The 73 
primary hypothesis of the study is that vegans have higher HR/shorter interbeat intervals 74 
(IBI) and lower HRV compared to omnivores. Exploratory analysis of plasma 20 : 5n-3 and 75 
22 : 6n-3 derived lipid mediator concentrations was conducted in order to provide 76 
mechanistic hypothesis-generating data that may help explain differences in HR/IBI/HRV 77 
between low and high LC n-3 PUFA status groups. 78 
Materials and Methods 79 
The present study was conducted according to the guidelines laid down in the Declaration of 80 
Helsinki, and all procedures involving human subjects were approved by the research ethics 81 
committee of King’s College London (BDM/12/13-84). Written informed consent was 82 
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obtained from each subject. Twenty-three healthy, non-smoking men and women, aged 40-70 83 
y who had been following a vegan diet for at least 2 years were compared with 24 age- and 84 
BMI-matched healthy participants who followed a mixed diet including meat, fish, eggs and 85 
dairy-containing foods (omnivores). Primary outcome variables were HR/IBI and time 86 
domain parameters of different components of HRV: SDNN (standard deviation of normal-87 
to-normal intervals: the most commonly reported marker of HRV and an indication of overall 88 
HRV, mainly determined by day/night differences) and RMSSD (square root of the mean of 89 
the sum of the squares of differences between adjacent NN intervals; an indicator of beat-to-90 
beat, respiration-driven variability representing parasympathetic cardiac regulation). 91 
Secondary outcome variables included: other time and frequency domain and non-linear 92 
parameters of HRV, erythrocyte and plasma fatty acid composition, plasma oxygenated lipid 93 
mediator profile, fasting plasma lipid profile, vitamin B12, serum 25-hydroxyvitamin D, 94 
interleukin-6 (IL-6), fasting plasma glucose, blood pressure, body composition and 95 
background diet in order to compare risk factors for CVD in vegans and omnivores. A sample 96 
size of 23 in each group has a 80% power to detect a difference between SDNN means of 25 97 
ms and between RMSSD means of 15 ms with a significance level of 0.05 (two-tailed), based 98 
on SDs of 30 ms and 18 ms respectively obtained from sleep-time HRV recordings in a 99 
previous cohort of middle-aged to older healthy men and women(31). Participants were 100 
recruited by distributing adverts to vegan organisations and societies. Omnivore participants 101 
were recruited through internal and external email circulars and posters amongst university 102 
students and staff. The study was also promoted via social media, flyer distributions to vegan 103 
restaurants and vegan food shops throughout London, and at various vegan food events. 104 
Volunteers who responded to advertisements were given more information about the study, 105 
completed an initial eligibility questionnaire via telephone or e-mail and, if eligible, were 106 
provided with a study information sheet. Exclusion criteria included a reported history of 107 
CVD, diabetes, cancer (excluding basal cell carcinoma) in the past five years, chronic renal, 108 
liver or inflammatory bowel disease, history of drug or alcohol abuse (previous weekly 109 
alcohol intake >60 units/men or 50 units/women), current self-reported weekly alcohol intake 110 
exceeding 28 units, current use of marine n-3 supplements, pregnancy, weight change of 111 
more than 3 kg in the previous 2 months, and BMI <18.5 and >35 kg/m2. Vegan subjects 112 
were enrolled on the study along with omnivore controls, aiming to match for sex, age (±5 y) 113 
and BMI (±2 kg/m2). A validated food frequency questionnaire(32) was used to verify self-114 
classification of dietary status of eligible volunteers and to provide supplementary 115 
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information on habitual dietary intakes. Analysis was carried out using an Excel spreadsheet 116 
that incorporated additional food composition data on LC n-3 PUFA contents of foods other 117 
than fish (meat, dairy, eggs). 118 
Participants attended one study visit, which took place in the morning. Volunteers were 119 
instructed to fast for 12 h before the visit and consume nothing but water until attending the 120 
clinic. Once written informed consent was obtained, seated blood pressure was measured in 121 
triplicate using an A&D Medical UA-767Plus (San Jose, USA) upper arm automatic blood 122 
pressure monitor, in accordance with guidelines from the British Hypertension Society 123 
(BHS). Height, body weight and percentage body fat, and waist circumference (WC) were 124 
measured using a stadiometer, a Tanita weighing scale (Tanita UK Ltd, model: BC-418 MA; 125 
Middlesex, UK) and a tape measure, respectively. Participants completed the food frequency 126 
questionnaire, which was checked for completeness and any missing data verified directly 127 
with the participant. Fasting plasma glucose and serum lipids, serum liver function markers, 128 
and whole blood haematology was analysed on the same day in fresh blood samples, and 129 
further plasma aliquots were frozen at -70 °C until analysis of fatty acid and lipid mediator 130 
profiles could take place. Erythrocytes were washed with saline and lysed. The erythrocyte 131 
lysate was de-proteinised in the presence of butylated hydroxytoluene, chloroform was added 132 
to extract lipids then centrifuged as previously described (33); supernatant was frozen at -20 ºC 133 
until analysis for fatty acid composition could be conducted (33). An Actiheart monitor was 134 
fitted on the chest (CamNtech Ltd, Cambridge, UK), which they wore for 24 h. A diary was 135 
provided during the recording period to keep a register of all the daily activities 136 
(activities/exercise, meals or naps).  137 
Heart rate variability measurements 138 
IBI and continuous HR were measured for approximately 24 h using Actiheart monitors 139 
(Camntech Ltd, Cambridge, UK), which are small, light-weight (<10g) waterproof devices 140 
that also contain piezoelectric sensors to record acceleration in the vertical plane (counts per 141 
minute, cpm) as a measure of physical activity (34). Before the monitor could be fitted, the 142 
area of skin was prepared including shaving of chest hair where required, using alcohol wipes 143 
to clean and dry the skin and use of an abrasive pad (UnilectTM) to remove the top layer of 144 
skin cells. Two ECG electrodes (SP-50, 50mm round, Pulse Medical) were placed on the 145 
chest to fit the Actiheart monitor. A short signal test involving a 5 minute walk was 146 
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performed before programming for the 24h recording to confirm adequate signal-to-noise 147 
ratio. Data processing of the 24 h IBI recordings was carried out using the Actiheart software 148 
(version 4.0.91, CamNtech Ltd, Cambridge, UK) and Kubios HRV analysis software 149 
(Biosignal Analysis and Medical Imaging Group, Department of Physics, University of 150 
Kuopio, Finland)(35). Heart rate variability (HRV), HR/IBI and accelerometry data(34) were 151 
analysed for the full length of recording time (minimum of 18 h, up to 24 h). Further analysis 152 
was carried on a standardised day-time period of 8 h and sleep-time period of 2 h to remove 153 
the influence of variability in recording duration on HRV parameters. HRV outcomes 154 
included time and frequency domain parameters; time domain parameters are based on the 155 
time intervals between adjacent QRS complexes (normal-to-normal (NN) intervals) whereas 156 
frequency domain parameters employ power spectral analysis of NN intervals to determine 157 
the power (variance) within frequency bands (36). Time domain parameters included SDNN, 158 
standard deviation of the average NN intervals in 5 min segments of the whole recording 159 
(SDANN), RMSSD, the percentage of adjacent NN intervals that differed by more than 50% 160 
(pNN50), and triangular index (Ti), the integral of the density distribution (the number of all 161 
NN intervals) divided by the maximum of the density distribution. Frequency domain 162 
parameters included high frequency (HF), low frequency (LF), and very low frequency 163 
(VLF) power, and the ratio of the LF and HF frequency band powers (LF/HF). A non-linear 164 
parameter using Poincaré plots of short term variability (SD1) against long term variability 165 
(SD2) was also calculated as a measure of complexity of HRV distribution over the duration 166 
of the recording. SDNN, LF and Ti represent overall variability. Short-term (beat-to-beat) 167 
components of HRV include RMSSD, pNN50, and HF. SDANN and VLF reflect longer-168 
phase components of variability. 169 
Fatty acid analysis 170 
Proportions of fatty acids in whole plasma and erythrocyte membranes were analysed by GC 171 
(Agilent 7890A GC; Agilent Technologies) with a BPX70 GC column (length 25 m, internal 172 
diameter 0.32 mm, film thickness 0.25 µm) custom designed for separation of fatty acid 173 
methyl esters (SGE Analytic Science) following transesterification, as previously 174 
described(37), but substituting toluene for benzene and using pentadecanoic acid as an internal 175 
standard. Since total plasma concentrations of fatty acids differ in vegans compared to 176 
omnivores, individual plasma fatty acids were compared between groups as weight 177 
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percentages of the sum of fatty acids (% weight)  (38) The omega-3 index was defined as the 178 
sum of % weight EPA+DHA in erythrocytes. 179 
Mediator Lipidomics  180 
Prostanoids and hydroxy fatty acids derived from dihomo-gamma-linolenic acid (DGLA; 20 : 181 
3n-6), linoleic acid (LA; 18 : 2n-6), 18 : 3n-3, arachidonic acid (AA; 20 : 4n-6), 20 : 5n-3 and 182 
22 : 6n-3 were extracted from plasma and analysed by ultraperformance liquid 183 
chromatography with electrospray ionization and tandem mass spectrometry (LC/ESI-184 
MS/MS) as previously described (39). Briefly, samples were  extracted in 15 % (v/v) 185 
methanol, and internal standards were added (20 ng each of PGB2-d4, 12-HETE-d8,  8,9-186 
EET-d11 and 8(9)-DHET-d11. Lipid extracts were semi-purified using solid phase extraction 187 
(C18-E cartridges; 500 mg, 6 ml; Phenomenex, Macclesfield, UK), and dried under nitrogen, 188 
before reconstitution in ethanol for analysis. Chromatographic separation was performed on a 189 
C18 column (Acquity UPLC BEH, 1.7 µm, 2.1 x 50 mm; Waters) using a gradient of 190 
acidified acetonitrile and water (Acquity Ultraperformance Liquid Chromatography and 191 
Xevo triple quadrupole mass spectrometer, Water, UK). Analytes were recorded using 192 
multiple reaction monitoring (MRM) assays, using the transitions reported in Astarita et al. 193 
(27) and quantified using calibration lines constructed with commercially available standards 194 
(Cayman, USA).  195 
Blood biochemistry analysis 196 
Blood samples were collected into fluoride oxalate tubes for glucose analysis and SST™ II 197 
tubes for TAG, total cholesterol, and HDL cholesterol, vitamin B12, 25-hydroxy vitamin D 198 
and interleukin-6 (IL-6) analysis; plasma and serum were stored frozen at -40 °C until 199 
analysis (Becton Dickinson, UK). Analyses of full blood counts, plasma glucose, serum 200 
lipids, vitamins, and IL-6 were determined by a Clinical Pathology Accredited (CPA) 201 
Clinical Biochemistry laboratory (ViaPath, Kings College Hospital, London). Glucose and 202 
lipids were analysed following enzymatic methods using reagents supplied by Bayer 203 
Diagnostics Europe Ltd (Bayer House, Strawberry Hill, Newbery, Berks) using an ADVIA 204 
2400 analyser (Sieman’s Healthcare Diagnostics, Frimley, Surrey, UK). IL-6 was analysed 205 
using a high sensitivity cytokine chip array assay (Human cytokine HS X biochip, Randox 206 
Laboratories Limited, County Antrim). Serum vitamin D and B12 concentrations were 207 
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analysed using the ADVIA Centaur total Vitamin D and Vitamin B12 immunoassays 208 
(Siemens Healthcare Diagnostics Ltd, Frimley, Surrey, UK).  209 
Statistical analysis 210 
Statistical analyses were performed using IBM SPSS Statistics 21.0 (Statistical Product and 211 
Service Solutions, IBM Corp). Chi-squared tests for categorical variables and independent 212 
samples t-test for continuous variables were used to assess the differences between vegan and 213 
omnivore subjects’ characteristics, dietary intakes, erythrocyte and plasma fatty acids, and 214 
lipid mediators. Non-normally distributed data were normalised by natural logarithm (LN) 215 
(results shown as geometric means with 95% CI) before analysis by independent t-test. If LN 216 
transformation failed to yield a normal distribution, a Mann-Whitney U test was applied to 217 
compare groups (results shown as medians with lower and upper quartiles). In the case of 218 
lipid mediators, results from non-normally distributed data analysed by Mann-Whitney U test 219 
were shown as medians with minimum and maximum values due to the proportion of 220 
undetectable concentrations of LC n-3 PUFA-derived mediators in omnivores as well as 221 
vegans. 222 
For HRV analysis, normally distributed raw data or LN transformed data were analysed by 223 
univariate ANCOVA, adjusted for sex, age, BMI and, in the case of day-time and 24 h data, 224 
physical activity (accelerometry data). Results are expressed as estimated marginal means 225 
(95% CI), adjusted for gender, age, BMI and 24 h activity for 24 h HRV and sleep-time – 226 
day-time HRV, or gender, age, BMI and 8 h activity for 8 h day-time HRV, or adjusted for 227 
gender, age and BMI only for 2 h sleep-time. Estimated marginal means and 95% CI from 228 
data that were LN transformed before analysis by ANCOVA were back-transformed and 229 
expressed as geometric means (95% CI). Data that could not be normalised by LN 230 
transformation were analysed using Mann-Whitney U test and significance values are 231 
presented unadjusted, with results shown as medians (lower and upper quartiles).  232 
Results 233 
Participant characteristics 234 
Figure 1 shows the flow of participants through the study. Subject characteristics of the 47 235 
participants who completed the study are presented in Table 1. The mean ages of vegans (8 236 
men, 15 women) and omnivores (12 men, 12 women) were 49 y (SD 8) and 54 y (SD 9) 237 
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respectively, and there were no significant differences in mean age or BMI, or distributions of 238 
sex between groups, although the sex distributions were not fully balanced across groups. 239 
Furthermore there were no significant differences in other markers of body composition (% 240 
body fat, waist circumference). Seated resting heart rate was on average 7 bpm higher and 241 
systolic blood pressure was 7 mm Hg lower in vegans compared to omnivores; there was no 242 
difference in mean seated diastolic blood pressure (Table 1). Fasting serum total and LN 243 
serum LDL cholesterol concentrations were lower in vegans compared to omnivores, but 244 
there were no differences in mean fasting plasma glucose, LN serum triacylglycerol, serum 245 
HDL cholesterol, serum vitamin B12, 25-hydroxy vitamin D or interleukin-6 concentrations, 246 
nor blood haemoglobin concentrations, indicating that the vegan group did not differ in 247 
vitamin D status and were likely to be taking dietary vitamin B12 supplements. Analysis of 248 
food frequency questionnaires (Table 1) showed that 61% of vegans reported taking vitamin 249 
B12 supplements, and suggested that vegans and omnivores had comparable total energy and 250 
percentage energy as fat intakes. Omnivores reported significantly higher protein (%E), 251 
saturated fat (%E) and food-derived vitamin B12 (µg) intakes and vegans had significantly 252 
higher carbohydrate (%E), total PUFA (%E), and 18 : 2n-6 (g) intakes. There were no 253 
differences in reported 18 : 3n-3 (g) intakes. As expected, vegans reported no dietary intake 254 
of 20 : 5n-3 and 22 : 6n-3, hence omnivores obtained significantly higher intake of these fatty 255 
acids, with estimated median intakes (IQR) of 0.14 g/d (0.09, 0.24) and 0.45 g/d (0.30, 0.81) 256 
for 20 : 5n-3 and 22 : 6n-3 respectively. A subset (12 omnivore and 8 vegan participants) 257 
completed 4-day food diaries (data not shown); analyses of these supported the food 258 
frequency questionnaire data. 259 
Fatty acid and lipid mediator profiles 260 
Vegans had a significantly higher proportion of plasma and erythrocyte 18 : 2n-6, plasma 18 : 261 
3n-3 and erythrocyte 20:3 n-6 compared to omnivores (Table 2). Both whole plasma and 262 
erythrocyte membrane proportions of 20 : 5n-3 and 22 : 6n-3, plasma palmitic acid (16 : 0), 263 
and erythrocyte docosapentaenoic acid n-3 (22 : 5n-3) and palmitoleic acid (16 : 1n-7) were 264 
significantly lower in vegans compared to omnivores. Vegans had a significantly lower 265 
omega-3 index, with a geometric mean of 2.7% compared to 5.4% in omnivores, although 266 
both groups would be considered below the proposed omega-3 index cut-off of >8% for 267 
optimal cardiovascular disease protection (8). Erythrocyte 18 : 2n-6:18 : 3n-3 ratios were 268 
inversely correlated with erythrocyte 20 : 5n-3 contents in vegans (r = -0.541, P = 0.008, n = 269 
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23), but not 22 : 5n-3 or 22 : 6n-3 contents; with no significant correlations in the erythrocyte 270 
lipids of omnivores. In plasma, the ratio of 18 : 2n-6:18 : 3n-3 was inversely correlated with 271 
plasma 22 : 5n-3 (r = -0. 576, P = 0.004, n = 23) and 22 : 6n-3  (r = -0.498, P = 0.016, n = 272 
23) in vegans and plasma 22 : 5n-3 only in omnivores (r = -0.474, P = 0.019, n = 24). 273 
Table 3 shows n-3 and n-6 PUFA-derived lipid mediators evaluated in the fasting plasma of 274 
the two study groups. A complete diagrammatic list of all lipid mediators included in the 275 
analysis protocol, including those that were and were not detectable in the plasma of this 276 
study population is given in Figures 2A and 2B. In general, the lipid mediators derived from 277 
n-6 PUFAs (mainly 20 : 3n-6 and 18 : 2n-6), and plant-derived n-3 PUFA (18 : 3n-3) were 278 
higher in vegans compared to omnivores, and the mediators derived from 20 : 5n-3 and 22 : 279 
6n-3 were lower in vegans compared to omnivores, showing a clear difference in the 280 
lipidomic profile between the groups. SPMs (resolvins, protectins and maresins) were not 281 
detectable in the fasting plasma samples. Notably, in vegans there were markedly lower 282 
fasting plasma concentrations of 18-HEPE, an 20 : 5n-3-derived precursor marker for 283 
resolvin E1, and undetectable concentrations of 17-HDHA, a 22 : 6n-3-derived precursor 284 
marker for resolvin D1, resolvin D2, and PDX, an isomer of protectin D1. 14-HDHA, another 285 
mediator arising from 22 : 6n-3 and a precursor marker for the macrophage-derived maresin 286 
1, was also much lower in vegan fasting plasma compared to omnivores (Table 3). In 287 
summary, these data show that vegans have increased blood concentrations of oxygenated 288 
metabolites of 18 : 2n-6 and 18 : 3n-3 compared to omnivores, and very low or undetectable 289 
concentrations of LC n-3 PUFA-derived oxygenated metabolites. 290 
Heart rate and heart rate variability 291 
Twenty-four hour  292 
The average duration of the 24 h interbeat interval recording was 21:02 h (95% CI 20:11, 293 
21:52); for day-time analysis it was 13:08 h (95% CI 12:38, 13:38) and for sleep-time 294 
analysis it was 5:56 h (95% CI 5:25, 6:27). Only recordings with a minimum of 18 h were 295 
included in the 24 h physical activity, IBI, HR and SDNN analysis.  296 
Vegans had higher 24 h HRV than omnivores as shown in Table 4: SDNN, SDANN, and 297 
VLF were higher in vegans. Differences in these parameters indicate greater variability in 298 
longer-phase cycles in the vegan group during the 24 h period, whereas beat-to-beat 299 
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(parasympathetically driven) variability (RMSSD, PNN50 and HF) and IBI/HR were not 300 
different between groups over the 24 h period. This is substantiated by much greater sleep-301 
time minus day-time differences in mean IBI/HR, indicating that vegans experience a greater 302 
drop in heart rate from day to night compared to omnivores, due to having faster day-time 303 
heart rates. 304 
Day-time  305 
Day-time analysis was carried out on the first 8 h segment of data following fitting of the 306 
monitor on the morning of the study visit, excluding noisy sections where signal was poor, in 307 
order to standardise the length of recording. There was no difference in physical activity 308 
levels as assessed by accelerometry between vegans and omnivores. IBI was significantly 309 
shorter in vegans (reciprocal to heart rate, for which group differences fell just short of 310 
statistical significance) during the day compared to omnivores (Table 4). In contrast to the 24 311 
h measurement period, HRV was reduced in vegans during the day compared to omnivores: 312 
this was observed in parameters of overall variability (SDNN, LF, although not in triangular 313 
index) and the beat-to-beat parameters of variability (RMSSD, PNN50, HF). To summarise, 314 
during day-time waking hours, vegans had shorter IBI/faster heart rates and in accordance 315 
with this, they had reduced beat-to-beat HRV, compared to omnivores, even after adjusting 316 
for physical activity and other covariates. 317 
Nocturnal sleep-time  318 
Sleep-time analysis was carried out on the first 2 h of sleep data, excluding periods of 319 
awakening as determined by increases in accelerometry counts per min, in order to 320 
standardise the length of recording. Longer segments were not available for all participants 321 
and therefore were not included in the analysis. There were no significant differences for any 322 
of the parameters between groups. 323 
Nocturnal sleep-time minus day-time differences in heart rate/interbeat intervals and beat-to-324 
beat heart rate variability 325 
Circadian changes are a key determinant of variability in heart rate over 24 h, measured as 24 326 
h SDNN. Differences in mean nocturnal sleep-time and day-time IBIs are a significant factor 327 
in the size of the SDNN value. As described above, the sleep-time minus day-time 328 
differences in HR/IBI were statistically significant, with the mean decrease in HR/increase in 329 
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IBI from day-time to sleep-time being distinctly larger in vegans compared to omnivores 330 
(Table 4). The lack of difference in sleep-time heart rate between groups, together with 331 
observations of shorter IBI (and non-statistically significant faster HR) during the day in 332 
vegans, suggests that the larger night-day difference in vegans is a result of greater circadian 333 
fluctuations in sympathetic-parasympathetic balance. Sleep-time minus day-time HRV also 334 
reflects the degree of circadian modulation of autonomic regulation of HR in both vegans and 335 
omnivores. The larger increases in beat-to-beat HRV parameters (RMSSD, HF, PNN50) 336 
during nocturnal sleep may indicate a greater suppression of parasympathetic regulation 337 
during day-time waking hours in vegans when considered alongside the shorter mean day-338 
time IBI in this group compared to omnivores.  339 
 340 
DISCUSSION 341 
Low HRV is associated with mortality after a myocardial infarction (21; 40; 41) and risk of 342 
cardiac events in the general population (23). Associations between increased n-3 PUFA 343 
consumption and higher HRV(42; 43; 44; 45), and lower heart rates(16), suggests that populations 344 
with very low n-3 PUFA tissue status might be at greater risk of arrhythmic events or sudden 345 
cardiac death. Vegetarians/vegans in the Adventist Health Study (46), EPIC-Oxford cohort(47), 346 
and 5 combined cohorts(48) have been reported to have lower risk of coronary heart disease 347 
(CHD) than non-vegetarians. However, a recent study of 2 combined population cohorts 348 
(EPIC-Oxford and the earlier Oxford Vegetarian Study cohort) reported similar rates of all-349 
cause mortality and no clear differences between vegans and comparable regular meat-eaters, 350 
fish-eaters and vegetarians in mortality from CHD up to the age of 90 years (49), despite the 351 
fact that vegan populations have lower CHD risk factors such as blood pressure(14; 15), plasma 352 
lipids (12; 13) and lower body mass index (10; 11) compared to populations that eat foods of 353 
animal origin. Although the latter findings do not preclude a lower risk of premature CHD in 354 
vegans, the notion that cardiovascular health of elderly vegans might be further optimised by 355 
increased intakes of dietary long chain n-3 PUFA remains a possibility. 356 
We hypothesised that a population with low tissue LC n-3 PUFA status would have higher 357 
heart rates and lower HRV, and vegans were chosen as a clearly defined group that could be 358 
considered as a model to test this hypothesis. As expected, we observed marked differences 359 
between vegans and omnivores in their tissue n-3 PUFA status, as represented by erythrocyte 360 
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lipid fatty acid composition (an indicator of longer-term PUFA intake due to the 4-month 361 
lifespan of an average red blood cell (50)). These findings were supported by differences in the 362 
plasma fatty acid composition and self-reported dietary LC n-3 PUFA intakes. The average 363 
erythrocyte omega-3 index in the omnivore group was lower than indices reported previously 364 
for a meat- and fish-eating UK population (51; 52; 53), but differences between the groups 365 
studied here were clear-cut. Inverse relationships were observed between erythrocyte 18 : 2n-366 
6 : 18 : 3n-3 ratios and erythrocyte 20 : 5n-3 in the vegan group. This supports existing 367 
evidence that higher dietary intakes of 18 : 2n-6, an n-6 PUFA which is abundant in 368 
omnivore diets but even more so in vegan/vegetarian diets(5), may inhibit conversion of 18 : 369 
3n-3 to longer chain n-3 PUFA(54).  370 
The observed group differences in heart rate and HRV were more complex than 371 
hypothesised, mainly due to divergence in night/day differences. Differences in all primary 372 
outcome variables - HR/IBI, SDNN (overall HRV), and RMSSD (beat-to-beat HRV) - were 373 
observed between groups but the nature of the difference depended on whether analysis was 374 
carried out over the full 24 h or only during day-time waking hours. In line with the 375 
hypothesis, mean day-time HR was higher/IBI shorter and overall (SDNN) and beat-to-beat 376 
HRV (RMSSD, PNN50%, HF) was lower in vegans, even following adjustment for physical 377 
activity during the same 8 h period. These observations might indicate that low omega-3 378 
status could lead to either a predominance of sympathetic regulation, a greater withdrawal of 379 
parasympathetic activity, or possibly, due to depletion of longer chain n-3 PUFA in 380 
cardiomyocyte membranes, there is a greater stimulation of pacemaker activity despite a 381 
normal level of sympathetic neural transmission during waking hours. However, it is also 382 
possible that the differences in HRV observed in vegans and omnivores are unrelated to LC 383 
n-3 PUFA tissue status; this would require investigation with a dietary intervention trial. A 384 
recent review on omega-3 fatty acids and effects on heart rate and HRV has argued that, 385 
according to evidence from animal models, it is more likely that 22 : 6n-3 is acting to reduce 386 
heart rate via modulation of pacemaker activity rather than changes in cardiac autonomic 387 
neural regulation(18), although the role of the 22 : 6n-3-derived SPM, neuroprotectin D1 388 
(PD1), in protecting the nervous system from inflammation-related injury shows that 22 : 6n-389 
3-dependent physiological mechanisms exist in synapses and neural circuits in order to 390 
sustain neuronal function(55; 56). The stable precursor to PD1 and resolvin D1 (RvD1), 17-391 
HDHA , was not detected in the fasting plasma of any vegan subjects, whereas 9 out of 24 392 
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omnivores had detectable concentrations. There were also marked differences in 393 
concentrations of long chain n-3 PUFA-derived precursor markers to resolvin E1 (RvE1, 394 
from 18-HEPE) and maresin-1 (MaR1, from 14-HDHA). Venous blood plasma 395 
concentrations of lipid mediators in whole fasting plasma are likely to be an insensitive 396 
marker of capacity for autacoid release and activity in specific sites of inflamed tissue. 397 
Nevertheless, higher circulating plasma concentrations of SPM precursor markers may 398 
indicate ease of bioavailability for conversion to SPMs at times of need, which presents clear 399 
functional implications for populations with low tissue 20 : 5n-3 and 22 : 6n-3 stores.  400 
Although the vegan group were not deficient in other nutrients that are related to HRV, such 401 
as vitamin D (57)and vitamin B12(58), the nature of the study design means that we cannot 402 
exclude the influence of other dietary or lifestyle factors associated with the vegan lifestyle. 403 
The vegans reported almost half the intake of saturated fatty acids (% energy) as the 404 
omnivores, in agreement with results reported in larger vegan populations (59), and 405 
correspondingly lower amounts of 16 : 0 as a proportion of total plasma fatty acids and lower 406 
serum concentrations of LDL-C. However, these differences are less likely to exert a major 407 
influence on cardiac electrophysiology. Animal studies have shown that PUFA-feeding 408 
decreased vulnerability to arrhythmia compared to high SFA-feeding without any reduction 409 
in the proportion of membrane SFA, and high-MUFA feeding did not reduce arrhythmia 410 
compared to high-SFA diets (60). This suggests that SFA membrane composition is not a 411 
major determinant of vulnerability to arrhythmias and addition of LC n-3 PUFA (replacing 412 
mainly 18:1 and n-6 PUFAs) might be the most important determinant. In fact our small 413 
cross-sectional study showed that erythrocyte SFA proportions were not different between 414 
groups and that vegans had lower day-time HRV, and therefore potentially a greater risk of 415 
arrhythmia if there was also coronary atherosclerosis present, despite lower saturated fat 416 
intake. 417 
There may be other explanations for higher heart rate and reduced HRV in vegans that are not 418 
related to n-3 PUFA status and were not measured as part of this study, for example, 419 
susceptibility to psychological stress (although reduced self-reported stress and anxiety has 420 
been observed in 109 vegans compared to 228 omnivores(61)), and job-related activities, and 421 
possibly frequency/duration of using a bicycle (which would not have been detected by 422 
accelerometry). The effects of physical activity on HRV depend on the type and intensity of 423 
activity involved, but higher parasympathetically-regulated HRV parameters are associated 424 
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with greater levels of habitual physical activity (62). Since parasympathetically-regulated HRV 425 
parameters were lower in vegans during the day-time, then it suggests that either habitual 426 
physical activity levels were lower in vegans or some other factor associated with vegan diet 427 
and lifestyle, such as the depletion in tissue 20 : 5n-3 + 22 : 6n-3 content, counteracted the 428 
effect of habitual physical activity levels.  429 
No differences were observed between groups during a standardised 2 h sleep period. 430 
Previous research from our group showed increased longer-phase HRV (SDANN and VLF) 431 
in a middle-aged population at moderate risk of CVD during nocturnal sleep following 12 432 
months fish oil supplementation at doses of 0.45-1.8 g/d LC n-3 PUFA compared to a refined 433 
olive oil placebo(31). Consistent with this, fish consumption was positively related to VLF in a 434 
large cohort of older adults(25). Low VLF is associated with increased risk of mortality post-435 
myocardial infarction, particularly arrhythmic death(40). Since SDANN and VLF represent 436 
slowly changing periodic variability in heart rate in response to thermoregulatory and 437 
hormonal shifts that may particularly occur during sleep, then it is likely that the 2 h 438 
standardised period in the current study was too short to detect longer-phase differences in 439 
HRV between vegans and omnivores during sleep. 440 
Contrasting observations were made for longer-phase components of 24 h HRV, which 441 
represent changes in heart rates over sustained periods in response to periodic fluctuations in 442 
neurohormonal and circadian physiology rather than beat-to-beat variability. These 443 
components of HRV (SDNN, SDANN, and VLF) were higher, and Poincaré ratio was lower, 444 
over 24 h in vegans compared to omnivores; this may represent more pronounced 445 
neurohormonal rhythms in vegans, or they may just reflect the higher heart rate and reduced 446 
HRV experienced by vegans during waking hours relative to sleep-time due to reasons 447 
discussed above.  448 
Sub-clinical markers of inflammation have been linked to risk of cardiovascular events, 449 
vascular inflammation being the key, self-amplifying component of atherogenesis (63; 64; 65). 450 
Resolution of acute inflammatory responses is a critical, programmed factor in tissue repair 451 
and prevention of further pathological changes to tissues. SPMs derived from long chain n-3 452 
PUFA take over from the initiating lipid mediators, prostaglandins and leukotrienes, during 453 
the neutrophil-monocyte sequence, and play a functional role in ending acute inflammatory 454 
events by inhibition of neutrophil influx to the site of trauma, counter-regulating pro-455 
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inflammatory cytokines, and stimulating resolving macrophages to clear the products of the 456 
inflammatory response, thereby allowing the injured area to heal(66). In theory, low tissue 457 
availability of 20 : 5n-3, 22 : 5n-3 and 22 : 6n-3 could compromise resolution of acute 458 
inflammatory events increasing risk of chronic inflammation, although this is purely 459 
speculative at present. Increased circulating concentrations of RvE1 and precursor markers of 460 
resolvins (18-HEPE, 17-HDHA), and maresins (14-HDHA) have been demonstrated 461 
following n-3 PUFA supplementation(67), the same precursor markers that were found to be 462 
different in our comparison of vegans and omnivores. Our data show that a population with 463 
no dietary intake of marine n-3 PUFA have much lower or zero fasting plasma concentrations 464 
of these SPM precursor markers. It is not known whether individuals with low omega-3 465 
status have increased rates of 20 : 5n-3 /22 : 6n-3-derived mediator turnover as an adaptive 466 
mechanism to avoid compromising SPM availability. If this were the case, then it would be 467 
expected that having low pools of SPM precursors would have no functional consequences in 468 
vegans. Future research in this area should address whether populations with low-omega-3 469 
status are more at risk of having a pro-inflammatory profile.  470 
Vegans had greater concentrations of 18 : 3n-3 and 18 : 2n-6 derived lipid mediators that 471 
have a variety of deleterious and cytoprotective effects (68; 69). In the case of 18 : 2n-6, this is 472 
likely to be due to higher dietary intakes, as supported by FFQ estimates, proportions of total 473 
plasma fatty acids, and incorporation into erythrocyte membrane lipids (68; 70). Although 474 
plasma 18 : 3n-3 proportions of total fatty acids were higher in vegans, reported dietary 475 
intakes were not different; however, FFQ estimates of intakes are likely to underestimate true 476 
intakes due to incomplete food composition data. Vegans also had lower concentrations of 477 
markers of AA-derived prostanoid production (6-keto PGF1α – a marker of PGI2 synthesis, 478 
and 13,14-dihydro PGF2α,/13,14-dihydro-15-keto PGF2α - markers of PGF2α production). 479 
There were no differences between groups for a range of AA-derived LOX-catalysed 480 
mediators (HETEs), suggesting that the lipid mediator profile of vegans may not necessarily 481 
be entirely pro-inflammatory relative to omnivores. Few of these lipid mediators have been 482 
fully characterised regarding their functional effects, and evidence in animal and cell models 483 
to date suggests that 18 : 2n-6- and 20 : 4n-6-derived lipid mediators comprise a complex 484 
array of diverse bioactive molecules that induce a range of physiological effects in various 485 
tissues (71; 72; 73). 486 
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Previous work has also demonstrated that circulating pro-inflammatory cytokines may be 487 
reduced by fish oil supplementation, as reviewed by Calder (74; 75). We included a measure of 488 
low grade inflammation, IL-6, in our comparison between vegans and omnivores, but found 489 
no differences between groups. However, this does not necessarily indicate that there are no 490 
differences between groups in their capacity to inhibit or resolve acute inflammatory events 491 
since circulating cytokine concentrations have limited utility as biomarkers of inflammation 492 
that may be occurring in localised areas of tissue. Previous studies have shown that serum IL-493 
6 concentrations were inversely correlated with HRV in men with renal disease (76), metabolic 494 
syndrome (77) and young healthy subjects (78), although not not all studies agree (79). 495 
Downregulation of inflammatory cytokine gene expression plus increased production of pro-496 
resolving lipid mediators are two potential mechanisms whereby cardiac function might 497 
possibly be preserved by increased 20 : 5n-3 and 22 : 6n-3 intakes, by reducing inflammatory 498 
tissue damage in the brain and autonomic nerves, and also in the heart tissue itself. 499 
Limitations of the present study. 500 
The cross-sectional design limits our findings to being exploratory in nature and the 501 
associations between low omega-3 status and reduced HRV require confirmation by a 502 
randomised controlled trial of 20 : 5n-3 + 22 : 6n-3 supplementation in a population with an 503 
omega-3 index of <3%. The sample population size is small and although statistical power 504 
calculations were conducted for the primary HRV outcomes, the study may be underpowered 505 
to detect group differences in other more variable outcomes such as beat-to-beat heart rate. 506 
Multiple statistical testing was carried out to explore group differences in short- and long-507 
term, and time and frequency domain HRV, increasing the risk of generating false-positive 508 
results. There is no agreed upon method for correcting statistical analyses that involve the full 509 
set of HRV measures, but the dataset represents groupings of related outcomes rather than a 510 
large collection of disparate variables. The data presented here is consistent when comparing 511 
variables that represent similar physiological phenomenon.  For example, there are two time 512 
domain (RMSSD, pNN50) and one frequency domain (HF power) parameters of beat-to-beat 513 
variability. These are all vagally regulated and all show consistently that day-time beat-to-514 
beat HRV is lower in vegans compared to omnivores. Therefore, although Type I errors 515 
cannot be ruled out with complete certainty, it is reassuring that statistically significant 516 
differences between groups are supported by analogous parameters. The stated aim was to 517 
match groups for age, sex and BMI, but matching for sex was not wholly achieved. Any 518 
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influence of this imbalance in sex distribution on HRV results was minimised by adjusting 519 
for age, sex and BMI, in addition to activity levels for 24 h and day-time HRV, in the 520 
statistical model. Technical problems in obtaining good quality sleep-time HRV data limited 521 
the standardised duration of nocturnal HRV to 2 h which may have led to effects on longer 522 
phase HRV parameters being missed. However, the fact that heart rate variability was lower 523 
and mean IBI was shorter in vegans only during the day, and not over the whole 24 h period, 524 
suggests that there may be a diet-mental stress interaction during waking hours that resulted 525 
in a greater degree of sympathetic nervous system activity relative to parasympathetic 526 
activity. Future studies could investigate this further by measuring HRV responses under 527 
controlled mental stress conditions in populations with very low omega-3 indices compared 528 
to populations with optimum omega-3 indices. 529 
Summary 530 
The differences observed in parameters of cardiac electrophysiology and circulating lipid 531 
mediator concentrations between vegans and omnivores may contribute to the sum effect of 532 
diet and lifestyle on cardiovascular disease risk. The lower availability of long chain n-3 533 
PUFA-derived lipid mediators in vegans may influence anti-inflammatory capacity, although 534 
other differences in linoleic and α-linolenic acid-derived mediators feed into an array of 535 
disparate inflammatory pathways and the sum effect is difficult to predict. Crucially, this 536 
study presents novel information on associations between free-living, unsupplemented dietary 537 
PUFA intakes with lipid mediator profiles in humans.  538 
 539 
ACKNOWLEDGEMENTS 540 
We thank Anne-Catherine Perz, MaryJo Searle and Catherine Kidd (King’s College London) 541 
for assistance in blood sample processing. 542 
 543 
FINANCIAL SUPPORT 544 
This research was supported by King’s College London and  received no specific grant from 545 
any funding agency, commercial or not-for-profit sectors. 546 
Page 19 of 50
Cambridge University Press
British Journal of Nutrition
For Review Only
20 
 
 547 
CONFLICT OF INTEREST 548 
None 549 
 550 
AUTHORSHIP 551 
WLH, TABS and AMP conceived the research question and devised the study.  AMP 552 
conducted the study and analysed the data, with the assistance of HA-K. AN, ACK and RG 553 
provided lipidomic analytical expertise. All authors contributed to writing and editing the 554 
manuscript. 555 
Page 20 of 50
Cambridge University Press
British Journal of Nutrition
For Review Only
21 
 
FIGURE TITLES AND LEGENDS 556 
FIGURE 1. Consort diagram. 557 
(no legend) 558 
FIGURE 2A. Schematic outline of oxygenated species derivatives of n-6 polyunsaturated 559 
fatty acids, linoleic acid (LA; 18 : 2n-6), dihomo-γ-linolenic acid (DGLA; 20 : 3n-6) and 560 
arachidonic acid (AA; 20 : 4n-6), analysed in blood plasma of vegans and omnivores. B. 561 
Schematic outline of oxygenated species derivatives of n-3 polyunsaturated fatty acids, α-562 
linolenic acid (ALA; 18 : 3n-3), eicosapentaenoic acid (EPA; 20 : 5n-3) and docosahexaenoic 563 
acid (DHA; 22 : 6n-3), analysed in blood plasma of vegans and omnivores. 564 
Legend for FIGURE 2A: 565 
20 : 3n-6 (DGLA)-, 18 : 2n-6 (LA)- and 20 : 4n-6 (AA)-derived lipid mediators assayed in 566 
study participants’ plasma. Red = higher in vegans, blue = higher in omnivores, purple = no 567 
difference, white = not detected or below the limit of detection. HODE, 568 
hydroxyoctadecadienoic acid; OxoODE, oxooctadecadienoic acid; EKODE, 569 
epoxyketooctadecenoic acid; EpOME, epoxyoctadecenoic acid; DiHOME, 570 
dihydroxyoctadecenoic acid; PG, prostaglandin ; HETrE, hydroxyeicosatrienoic acid; TX, 571 
thromboxane; HETE, hydroxyeicosatetraenoic acid; EET, epoxyeicosatetraenoic acid; 572 
DHET, dihydroeicosatetraenoic acid; DiHETE,dihydroxyeicosatetraenoic acid ; HX, 573 
hepoxilin ; LT, leukotriene. 574 
 575 
Legend for FIGURE 2B: 576 
18 : 3n-3 (ALA)-, 20 : 5n-3 (EPA)- and 22 : 6n-3 (DHA)-derived lipid mediators assayed in 577 
study participants’ plasma.  Red = higher in vegans, blue = higher in omnivores, purple = no 578 
difference, white = not detected or below the limit of detection. HOTrE, 579 
hydroxyoctadecatrienoic acid; TX, thromboxane; PG, prostaglandin; HEPE, 580 
hydroxyeicosapentaenoic acid; Rv, resolvin; HDHA, hydroxydocosahexaenoic acid; PD, 581 
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protectin D; MaR, maresin; EpDPE, epoxydocosapentaenoic acid; 582 
DiHDPA,dihydroxydocosapentaenoic acid. 583 
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TABLE 1. Characteristics and background dietary intakes of vegan and omnivore participants 
 Omnivore (n=24) Vegan (n=23) P value
‡
 
 Number % Number %  
Gender       
   Male  12 50 8 35 0.292§ 
   Female  12 50 15 65 
Ethnicity      
   White  21 88 21 91 0.289§ 
   Black 
African/Caribbean 
0 0 1 5  
   South Asian  2 8 0 0  
   Other  1 4 1 5  
Vitamin B12 
supplement use  
8 33 14 61 0.059§ 
 Mean/geomet
ric 
mean*/media
n† 
SD/95% 
CI/IQR 
Mean/geometric 
mean*/median† 
SD/95% 
CI/IQR 
 
Age (years)  54 9.1 49 7.9 0.081 
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 Omnivore (n=24) Vegan (n=23) P value
‡
 
BMI (kg/m
2
)
 
 23.3 2.8 23.5 4.4 0.896 
Waist circumference  
(cm)     
     
       Male   91.7 6.5 97.2 5.9 0.165 
       Female   88.8 12.5 86.0 14.8 0.617 
% body fat       
       Male   19.3 7.9 21.1 5.9 0.572 
       Female 30.6 7.7 29.4 9.9 0.751 
Systolic BP (mmHg)  118 9.8 111 9.9 0.032 
Diastolic BP (mmHg)  75 9.3 74 8.2 0.703 
Heart Rate (bpm) 63 10.8 70 9.0 0.017 
Plasma glucose 
(mmol/L)  
5.2 0.4 5.1 0.4 0.616 
Serum triacylglycerol 
(mmol/L) 
*
 
0.77 0.66, 0.92 0.76 0.64, 
0.90 
0.849 
Serum total cholesterol 
(mmol/L) 
4.9   0.86 4.1   0.66 0.001 
Serum LDL-C  2.81  2.49, 3.17 2.16  1.94, 0.002 
Page 24 of 50
Cambridge University Press
British Journal of Nutrition
For Review Only
25 
 
 Omnivore (n=24) Vegan (n=23) P value
‡
 
(mmol/L)
 *
 2.41 
Serum HDL-C 
(mmol/L)  
     
       Male 1.52  0.35 1.29   0.23 0.118 
       Female 1.71   0.24 1.66  0.42 0.725 
Energy intake (MJ) 8.17   2.00 7.67   2.77 0.477 
Protein intake (%E) 16.6   2.2 13.3  2.4 < 0.001 
Carbohydrate intake 
(%E) 
49.2   7.3 56.5   11.6 0.013 
Total fat intake (%E) 33.8   5.9 30.9  9.5 0.216 
SFA intake (%E) 11.8   2.6 6.3   1.7 < 0.001 
MUFA intake (%E) 
†
 13.5  12.1,15.0 11.6  9.3,14.4 0.136 ║ 
PUFA intake (%E) 6.0 1.2 9.6 3.1 < 0.001 ║ 
18 : 2n-6  intake (g) 
†
 7.6 5.9, 10.2 10.5 7.3, 18.5 0.025 ║ 
18 : 3n-3 intake (g) 
†
 0.7 0.5, 1.0 0.8 0.5, 1.2 0.425 
20 : 5n-3 intake (g) 
†
 0.14  0.09, 0.24 0.00  0.00, 
0.00 
< 0.001 ║ 
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 Omnivore (n=24) Vegan (n=23) P value
‡
 
22 : 6n-3 intake (g) 
†
 0.45  0.30, 0.81 0.01  0.01, 
0.01 
< 0.001 ║ 
Serum vitamin B12 
(ng/L) 
442   216 358   117 0.108 
Haemoglobin (g/L)      
       Male 14.4   0.6 14.4   0.8 0.805 
       Female 13.2   1.0 13.5   1.0 0.460 
Serum 25-hydroxy 
vitamin D (nmol/L) 
54.3  ** 20.9 55.6   26.5 0.854 
Interleukin-6 (ng/L) 
†
 0.93  ** 0.25, 1.54 1.07  0.23, 
3.05 
0.701║ 
BMI. body mass index; BP, blood pressure; bpm, beats per minute; LDL-C, low density 
lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; SFA, saturated fatty 
acids; MUFA, monounsaturated fatty acids;  PUFA, polyunsaturated fatty acids; 18 : 2n-6 
(LA), linoleic acid; 18 : 3n-3 (ALA), alpha-linolenic acid; 20 : 5n-3 (EPA), eicosapentaenoic 
acid; 22 : 6n-3 (DHA), docosahexaenoic acid.  
Results are expressed as number of subjects (percentage) or mean with standard deviation, 
except where * denotes geometric mean with 95% confidence intervals, and  † denotes median 
with upper and lower quartiles.  
‡ shows use of independent samples t-test, except § Chi Square Test and ║ Mann-Whitney U 
test. ** n=23 due to sample loss. 
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TABLE 2. Plasma and erythrocyte fatty acid composition in vegan and omnivore participants (n=47). 
 Omnivore (n=24) Vegan (n=23) Difference between groups  
Plasma and erythrocyte 
fatty acids (weight %) 
Mean/geometric 
mean*/median† 
95% CI/IQR Mean/geometric 
mean*/median† 
95% 
CI/IQR 
Mean 
difference‡ 
95% CI P value║ 
Plasma        
16 : 0  20.8 20.4, 21.3 19.3 18.6, 20.0 -1.49 -2.31, -0.67 0.001 
16 : 1n-7  1.79 1.48, 2.10 1.11 0.91, 1.32 -0.67 -1.04, -0.31 0.001 
18 : 0  7.62 7.30, 7.94 7.60 7.15, 8.04 -0.02 -0.55, 0.50 0.931 
18 : 1n-9  18.5 17.6, 19.3 18.9 17.9, 19.8 0.37 -0.89, 1.62 0.559 
18 : 2n-6  27.1 26.0, 28.2 33.1 31.9, 34.4 6.06 4.43, 7.68 < 0.001 
18 : 3n-3 * 0.53 0.48, 0.59 0.71 0.59, 0.85 1.34§ 1.09, 1.64 0.006 
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 Omnivore (n=24) Vegan (n=23) Difference between groups  
Plasma and erythrocyte 
fatty acids (weight %) 
Mean/geometric 
mean*/median† 
95% CI/IQR Mean/geometric 
mean*/median† 
95% 
CI/IQR 
Mean 
difference‡ 
95% CI P value║ 
20 : 3n-6  1.42 1.28, 1.55 1.42 1.28, 1.57 0.01 -0.18, 0.20 0.952 
20 : 4n-6  6.68 6.12, 7.25 6.55 5.94, 7.16 -0.13 -0.94, 0.68 0.745 
20 : 5n-3 * 1.03 0.79, 1.34 0.47 0.40, 0.55 0.46§ 0.34, 0.62 < 0.001 
22 : 4n-6 * 0.20 0.19, 0.21 0.23 0.21, 0.25 1.14§ 1.01, 1.28 0.036 
22 : 5n-6  0.26 0.21, 0.30 0.20 0.15, 0.26 -0.05 -0.12, 0.02 0.146 
22 : 5n-3  0.59 0.53, 0.64 0.51 0.44, 0.59 -0.07 -0.16, 0.02 0.113 
22 : 6n-3 * 2.23 1.94, 2.57 0.91 0.80, 1.05 0.41§ 0.34, 0.49 < 0.001 
Erythrocyte         
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 Omnivore (n=24) Vegan (n=23) Difference between groups  
Plasma and erythrocyte 
fatty acids (weight %) 
Mean/geometric 
mean*/median† 
95% CI/IQR Mean/geometric 
mean*/median† 
95% 
CI/IQR 
Mean 
difference‡ 
95% CI P value║ 
16 : 0  16.8 15.4, 18.2 17.6 16.7, 18.6 0.81 -0.87, 2.48 0.337 
16 : 1n-7 † 0.41 0.30, 1.57 0.31 0.21, 0.50 - - 0.016¶ 
18 : 0 * 15.6 14.9, 16.3 16.3 15.6, 17.1 1.05§ 0.99, 1.14 0.135 
18 : 1n-9  15.7 15.1, 16.3 15.4 14.7, 16.2 -0.23 -1.15, 0.68 0.609 
18 : 2n-6  11.7 11.0, 12.3 13.3 12.5, 14.1 1.64 0.64, 2.64 0.002 
18 : 3n-3 * 0.34 0.26, 0.45 0.32 0.27, 0.38 0.92§ 0.67, 1.27 0.610 
20 : 3n-6 * 1.78 1.64, 1.94 2.02 1.84, 2.22 1.13§ 1.01, 1.28 0.042 
20 : 4n-6  15.9 14.9, 16.9 15.6 14.4, 16.9 -0.27 -1.82, 1.27 0.725 
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 Omnivore (n=24) Vegan (n=23) Difference between groups  
Plasma and erythrocyte 
fatty acids (weight %) 
Mean/geometric 
mean*/median† 
95% CI/IQR Mean/geometric 
mean*/median† 
95% 
CI/IQR 
Mean 
difference‡ 
95% CI P value║ 
20 : 5n-3  1.26 1.07, 1.45 0.67 0.52, 0.81 -0.59 -0.83, -0.36 < 0.001 
22 : 4n-6  2.75 2.47, 3.03 3.83 3.50, 4.16 1.08 0.66, 1.50 < 0.001 
22 : 5n-6  0.38 0.27, 0.49 0.52 0.40, 0.64 0.14 -0.02, 0.30 0.078 
22 : 5n-3  2.62 2.36, 2.88 2.15 1.94, 2.36 -0.47 -0.80, -0.15 0.005 
22 : 6n-3 * 4.19 3.63, 4.83 2.07 1.85, 2.32 0.49§ 0.41, 0.59 < 0.001 
Omega 3 index * 5.42 4.73, 6.20 2.71 2.40, 3.05 0.50§ 0.42, 0.60 < 0.001 
16 : 0, palmitic acid; 16 : 1n-7, palmitoleic acid; 18 : 0, stearic acid; 18 : 1n-9, oleic acid; 18 : 2n-6, linoleic acid; 18 : 3n-3, α-linolenic acid; 20 : 
3n-6, dihomo-γ-linolenic acid; 20 : 4n-6, arachidonic acid; 20 : 5n-3, eicosapentaenoic acid; 22 : 5n-3, docosapentaenoic acid n-3; 22 : 6n-3, 
docosahexaenoic acid. Results are expressed as mean (95% CI), except where * denotes geometric means (95% CI) and † denotes median (lower 
and upper quartiles). ‡Mean ∆ vegan - omnivore (95% CI), except where § denotes exponents of mean differences in Ln values (the ratio of the 
geometric mean in vegans to that in omnivores, with 95% CI of the geometric mean ratios).  ║ P value obtained using independent samples t-test, 
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except where ¶ denotes use of Mann-Whitney U test where data remained not normally distributed following LN transformation. Total plasma 
fatty acid concentrations were (geometric means with 95% CI): omnivores (1869 mg/L, 1660, 2104; n=24), vegans (1998 mg/L, 1755, 2274; 
n=23); there were no significant differences between groups. 
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TABLE 3. Plasma concentrations of n-6 and n-3 PUFA-derived lipid mediators in vegan and omnivore participants (n=47). 
 
Omnivore (n=24) Vegan (n=23) 
 
Compound (ng/L) 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
P value║ 
n-6 PUFA-derived    
20 : 3n-6-derived 
    
  
15-HETrE 51.82 36.94, 66.70 53.87 39.78, 67.96 0.533 
13,14-dihydro-15-keto PGE1 * 17.45 9.52, 31.99 13.93 7.82, 24.78 0.519 
13,14-dihydro PGE1 † 0.000 0.000, 4.332 0.000 0.000, 76.928 0.001¶ 
18 : 2n-6-derived 
     
9-HODE * 2433 1982, 2988 5045 4067, 6260 <0.001 
9 OxoODE * 477 398, 571 994 771, 1282 <0.001 
13-HODE * 3320 2717, 4056 6536 5483, 7791 <0.001 
13 OxoODE 335 291, 379 537 467, 606 <0.001 
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Omnivore (n=24) Vegan (n=23) 
 
Compound (ng/L) 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
P value║ 
12,13-EpOME 389 326, 451 769 622, 917 <0.001 
12,13-DiHOME 2820 2159, 3480 5544 4527, 6561 <0.001 
9,10-EpOME * 258 220, 303 426 351, 518 <0.001 
9,10-DiHOME * 3199 2482, 4125 7400 5910, 9267 <0.001 
Trans EKODE * 300 248, 362 560 425, 738 <0.001 
20 : 4n-6-derived 
     
6-keto PGF1α † 8.20 0.000, 59.14 0.000 0.000, 4.49 <0.001¶ 
13,14-dihydro PGF2α * 48.4 34.57, 67.91 20.0 14.82, 26.97 <0.001 
13,14-dihydro-15-keto PGF2α † 0.000 0.000, 25.56 0.000 0.000, 12.79 0.016¶ 
13,14-dihydro-15-keto PGE2 * 3.67 2.584, 5.217 3.07 2.172, 4.347 0.459 
TXB2 * 10.3 7.57, 14.14 10.5 6.08, 18.05 0.968 
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Omnivore (n=24) Vegan (n=23) 
 
Compound (ng/L) 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
P value║ 
5-HETE * 124 96.4, 160.4 132 103.2, 168 0.738 
8-HETE 70.2 56.77, 83.57 74.5 62.33, 86.60 0.626 
9-HETE † 12.82 0.00, 70.99 0.000 0.000, 70.99 0.478¶ 
11-HETE 62.3 49.55, 75.13 59.7 49.68, 69.64 0.736 
12-HETE † 146.48 96.76, 1214.43 143.6 82.20, 1625.76 0.580¶ 
15-HETE 174 145, 203 186 158, 214 0.533 
20-HETE * 284 232, 348 290 229, 367 0.896 
5,6-DHET * 55.4 47.09, 65.19 52.0 41.29, 65.37 0.635 
8,9-DHET * 71.6 62.75, 81.81 82.1 67.40, 99.95 0.238 
11,12-DHET 204 173, 235 233 207, 260 0.147 
14,15-DHET 260 231, 290 312 272, 353 0.036 
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Omnivore (n=24) Vegan (n=23) 
 
Compound (ng/L) 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
P value║ 
      
n-3 PUFA-derived      
18 : 3n-3-derived      
9-HOTrE * 139 111, 173 206 170, 250 0.007 
13-HOTrE * 150 114, 198 245 201, 299 0.005 
20 : 5n-3-derived      
5-HEPE† 75.7 0.000, 462.2 21.4 0.000, 107.5 <0.001¶ 
8-HEPE†  15.2 0.000, 219.0 0.000 0.000, 21.0 <0.001¶ 
18-HEPE†  74.8 0.000, 624.8 0.000 0.000, 150.2 <0.001¶ 
22 : 6n-3-derived      
4-HDHA†  75.800 38.181, 413.405 45.734 0.000, 102.331 <0.001¶ 
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Omnivore (n=24) Vegan (n=23) 
 
Compound (ng/L) 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
Mean/geometric 
mean*/median† 
95% CI/minimum 
and maximum 
P value║ 
7-HDHA† 0.000 0.000, 202.374 0.000 0.000, 125.813 0.581¶ 
10-HDHA†  20.529 0.000, 197.107 0.000 0.000, 14.974 <0.001¶ 
11-HDHA†  0.000 0.000, 191.074 0.000 0.000, 0.000 0.022¶ 
13-HDHA†  19.255 0.000, 87.861 0.000 0.000, 0.000 <0.001¶ 
14-HDHA†  41.255 0.000, 299.686 0.000 0.000, 57.819 <0.001¶ 
17-HDHA†  0.000 0.000, 364.505 0.000 0.000, 0.000 0.001¶ 
20-HDHA†  107.538 44.088, 748.889 25.446 0.000, 105.464 <0.001¶ 
19,20- DiHDPA * 1448 1240, 1690 1098 878, 1374 0.040 
20 : 3n-6, dihomo-γ-linolenic acid; HETrE, hydroxyeicosatrienoic acid; PG, prostaglandin; 18 : 2n-6, linoleic acid; HODE, 
hydroxyoctadecadienoic acid; OxoODE, oxooctadecadienoic acid; EpOME, epoxyoctadecenoic acid; DiHOME, dihydroxyoctadecenoic acid; 
EKODE, epoxyketooctadecenoic acid; 20 : 4n-6, arachidonic acid; TX, thromboxane; HETE, hydroxyeicosatetraenoic acid; DHET, 
dihydroeicosatetraenoic acid; 18 : 3n-3, α-linolenic acid; HOTrE, hydroxyoctadecatrienoic acid; 20 : 5n-3, eicosapentaenoic acid; HEPE, 
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hydroxyeicosapentaenoic acid; 22 : 6n-3, docosahexaenoic acid; HDHA, hydroxydocosahexaenoic acid; DiHDPA, dihydroxydocosapentaenoic 
acid.  
Results are expressed as mean (95% CI), except where * denotes geometric means (95% CI) and † denotes median (minimum and maximum 
values).  
║ P value obtained using independent samples t-test, except where ¶ denotes use of Mann-Whitney U test where data remained not normally 
distributed following LN transformation.  
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TABLE 4. Physical activity, heart rate and heart rate variability parameters of vegan and 
omnivore participants over 24 h, day-time and sleep-time, with sleep – day differences 
(n=47). 
 Omnivore (n = 24 )  Vegan (n = 22*) P § 
 Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
 
Twenty-four hour measurement 
Activity, IBI and HR 
  Physical activity (cpm)¶†† 236 (196, 284) 285 (233, 348) 0.181 
  IBI (ms)††  845 (798, 892) 811 (760, 861) 0.336 
  HR (bpm)†† 75 (71, 79) 78 (74, 83) 0.210 
Time-domain HRV parameters 
  Ti 38 (33, 42) 41 (36, 46) 0.294 
  SDNN (ms)†† 145 (129, 162)   172 (154, 189) 0.039 
  SDANN (ms) 128 (114, 143) 155 (139, 170) 0.018 
  RMSSD (ms) ¶ 35 (31, 40) 35 (30, 40) 0.905 
  PNN50 (%) ¶ 8.9 (6.5, 12.2) 7.0 (5.0, 9.7) 0.299 
Frequency-domain HRV parameters 
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 Omnivore (n = 24 )  Vegan (n = 22*) P § 
 Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
 
  LF (ms2) ¶ 971 (786, 1198) 761 (608, 953) 0.130 
  HF (ms2) ¶ 350 (262, 467) 309 (227, 421) 0.567  
  VLF (ms2)  ¶ 12619 (10351, 15379) 17980 (14547, 22204) 0.022 
Non-linear methods 
  SD1:SD2 (Poincaré ratio)  0.13 (0.11, 0.14) 0.11 (0.10, 0.12) 0.051 
 
Day-time (8 hours) measurement 
Activity, IBI and HR 
  Physical activity (cpm)¶ 437 (347, 552) 443 (345, 570) 0.935 
  IBI (ms) 787 (745, 830) 721 (675, 766) 0.039 
  HR (bpm) 80 (76, 84) 86 (81, 91) 0.062 
Time-domain HRV parameters 
  Ti 31 (28, 34) 27 (24, 31) 0.135 
  SDNN (ms) 121 (109, 132) 101 (89, 113) 0.021 
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 Omnivore (n = 24 )  Vegan (n = 22*) P § 
 Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
 
  SDANN (ms) 100 (89, 111) 84 (73, 96) 0.056 
  RMSSD (ms)  34 (30, 38) 25 (20, 30) 0.009 
  PNN50 (%) ¶ 6.6 (4.6, 9.4) 2.7 (1.8, 3.9) 0.001 
Frequency-domain HRV parameters 
  LF (ms2)  908 (785, 1032) 628 (495, 761) 0.004 
  HF (ms2) ¶ 260 (198, 342) 135 (100, 181) 0.002 
  VLF (ms2)  ¶ 8325 (6894, 10052) 6470 (5277, 7929) 0.078 
Non-linear methods 
  SD1:SD2 (Poincaré ratio)  0.15 (0.13, 0.16) 0.13 (0.11, 0.15) 0.125 
Sleep-time (2 hours) measurement 
IBI and HR 
  IBI (ms) 965 (903, 1026) 991 (925, 1056) 0.568 
  HR (bpm) 64 (61, 68) 62 (59, 66) 0.475 
Time-domain HRV parameters 
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 Omnivore (n = 24 )  Vegan (n = 22*) P § 
 Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
 
  Ti 19 (16, 22) 18 (16, 21) 0.762 
  SDNN (ms) 78 (68, 88) 85 (75, 96) 0.324 
  SDANN (ms) ¶ 42 (36, 51) 44 (37, 54) 0.717 
  RMSSD (ms) ¶ 38 (32, 45) 44 (37, 53) 0.214 
  PNN50 (%) ¶ 10.9 (7.0, 16.9) 11.7 (7.3, 18.7) 0.826 
Frequency-domain HRV parameters 
  LF (ms2) ¶ 882 (646, 1205) 902 (647, 1256) 0.925 
  HF (ms2) ¶ 403 (280, 580) 464 (315, 684) 0.601 
  VLF (ms2)  ¶ 2881 (2215, 3744) 3519 (2661, 3744) 0.304 
Non-linear methods 
  SD1:SD2 (Poincaré ratio) ¶ 0.27 (0.23, 0.32) 0.28 (0.24, 0.33) 0.740 
Sleep-time – day-time differences 
IBI and HR 
   
  IBI (ms) 183 (139, 227) 270 (223, 317) 0.012 
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 Omnivore (n = 24 )  Vegan (n = 22*) P § 
 Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
Mean/geometric 
mean¶/median** (95% 
CI/IQR) 
 
  HR (bpm) -16 (-19, -13) -24 (-28, -20) 0.003 
Time-domain beat-to-beat HRV parameters 
  RMSSD (ms)  8 (1, 14) 22 (15, 29) 0.006 
  PNN50 (%)  6.4 (0.9, 11.8) 14.2 (8.5, 20.1) 0.058 
Frequency-domain beat-to-beat HRV parameters 
  HF (ms2) ** 127 (-12, 417) 234 (84, 988) 0.095║ 
Cpm, counts per minute; IBI, interbeat interval (also known as RR interval), the time interval 
between R spikes of the QRS complex; bpm, beats per minute; HRV, heart rate variability; 
Ti, total number of all NN intervals divided by the height of the histogram of all NN 
intervals; SDNN, standard deviation of all NN intervals (normal-to-normal intervals, similar 
to R-R, but on normalized IBI data); ms, milliseconds; SDANN, standard deviation of the 
averaged NN intervals, calculated from 5 min epochs; RMSSD, the square root of the mean 
of the sum of squares of differences between adjacent NN intervals; PNN50, percentage of 
adjacent NN intervals that differed by more than 50%; LF, low frequency power;  HF, high 
frequency power; VLF, very low frequency power; SD1:SD2,  the ratio of the SD of beat-to-
beat IBI variability (SD1) against the SD of long-term IBI variability (SD2).  
Results expressed as estimated marginal means (95% CI), adjusted for gender, age, BMI and 
24 h activity for 24 h HRV and sleep-time – day-time HRV, or 8 h activity for 8 h day-time, 
and adjusted for gender, age and BMI only for sleep-time. Sleep-time – day-time represents 
HR/IBI and beat-to-beat HRV during a standardized 2 h nocturnal sleep period minus a 
standardized 8 h day-time period, to indicate the difference between night and day. 
*Missing data from 1 subject due to unusable day-time HRV recording. 
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§ P value obtained using analysis of covariance for normally distributed raw or LN 
transformed data (adjusted for gender, age, BMI and activity for 24 h, day-time and sleep-
time – day-time differences, and adjusted for gender, age and BMI only for sleep-time), 
except for sleep-time – day-time differences in HF, where ║ denotes use of an unadjusted 
non-parametric test, the Mann-Whitney U test, where data remained not normally distributed 
following LN transformation. ¶ denotes geometric means (95% CI) and ** denotes medians 
(lower and upper quartiles). 
†† Only recordings >18 h included for 24 h physical activity, SDNN, IBI and HR data 
analysis, n 21 for omnivores and 19 for vegans.  
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Volunteers respond to advert by e-mail or telephone (n=127) 
Eligible volunteers were 
invited to attend a clinic 
visit (n=62) 
35 participants excluded: 
11 <40 y 
9 following vegan diet for <2 y 
6 taking EPA &/or DHA 
supplements 
2 vegetarians 
5 history of chronic disease 
2 quit smoking  <6 months ago 
6 dropped out – 
ceased 
communication 
4 dropped out – 
ceased 
communication 
2 excluded – 
1 did not attend, 
1 withdrew 
3 excluded – 2 
did not attend, 
1 withdrew 
Omnivores Vegans 
Omnivores invited to 
clinic visit (n=27) 
Vegans invited to 
clinic visit (n=25) 
Omnivores 
completing visit 
(n=24) 
Vegans completing 
visit (n=23) 
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